India Bulk Drug Makers Start Preparing for Ozempic Patent Expiry

Indian firms that make active pharmaceutical ingredients, or APIs, are gearing up to supply the basic ingredient that goes in making copies of Novo Nordisk A/S’s weight-loss drugs that are losing patent protection next year in several large markets....

Redirecting to full article...